Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons. | Front Cell Neurosci | 2022 | 36619669 | PubTator, text mining | PubMed |
| Parents' dilemma: A therapeutic decision for children with spinal muscular atrophy (SMA) type 1. | Front Pediatr | 2022 | 36619514 | PubTator, text mining | PubMed |
| Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: A large retrospective study from China. | Front Neurol | 2022 | 36605788 | PubTator, text mining | PubMed |
| Utility estimations of different health states of patients with type I, II, and III spinal muscular atrophy in China: A mixed approach study with patient and proxy-reported data. | Front Public Health | 2022 | 36605247 | PubTator, text mining | PubMed |
| Modeling neuromuscular diseases in zebrafish. | Front Mol Neurosci | 2022 | 36583079 | PubTator, text mining | PubMed |
| Nontraumatic Spinal Cord Injury: Epidemiology, Etiology and Management. | J Pers Med | 2022 | 36579590 | PubTator, text mining | PubMed |
| Addressing the implementation gap in advanced therapeutics for spinal muscular atrophy in the era of newborn screening programs. | Front Neurol | 2022 | 36578307 | PubTator, text mining | PubMed |
| Intronic variants in inborn errors of metabolism: Beyond the exome. | Front Genet | 2022 | 36561316 | PubTator, text mining | PubMed |
| Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders. | J Pers Med | 2022 | 36556200 | PubTator, text mining | PubMed |
| Parental Burden and Quality of Life in 5q-SMA Diagnosed by Newborn Screening. | Children (Basel) | 2022 | 36553273 | PubTator, text mining | PubMed |
| Prospective Analysis of Functional and Structural Changes in Patients with Spinal Muscular Atrophy-A Pilot Study. | Biomedicines | 2022 | 36551943 | PubTator, text mining | PubMed |
| The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study. | JMIR Res Protoc | 2022 | 36520510 | PubTator, text mining | PubMed |
| Newborn screening and gene therapy in SMA: Challenges related to vaccinations. | Front Neurol | 2022 | 36504644 | PubTator, text mining | PubMed |
| NSC Physiological Features in Spinal Muscular Atrophy: SMN Deficiency Effects on Neurogenesis. | Int J Mol Sci | 2022 | 36499528 | PubTator, text mining | PubMed |
| Is There a Role for Immunoregulatory and Antiviral Oligonucleotides Acting in the Extracellular Space? A Review and Hypothesis. | Int J Mol Sci | 2022 | 36498932 | PubTator, text mining | PubMed |
| Artificial genetic polymers against human pathologies. | Biol Direct | 2022 | 36474260 | PubTator, text mining | PubMed |
| Proximity-dependent biotinylation technologies for mapping RNA-protein interactions in live cells. | Front Mol Biosci | 2022 | 36452457 | PubTator, text mining | PubMed |
| Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD. | Clin Transl Med | 2022 | 36424805 | PubTator, text mining | PubMed |
| PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. | Genes (Basel) | 2022 | 36421785 | PubTator, text mining | PubMed |
| Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro. | Mol Ther Nucleic Acids | 2022 | 36420221 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=39